REGEMAT3D, a biotech company pioneer in the use of 3D printing for regenerative therapies.
Regemat 3D has raised $563K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in March 2022.
Regemat 3D's investors include Crowdcube.
Regemat 3D is headquartered in Armilla, Spain.
REGEMAT3D, a biotech company pioneer in the use of 3D printing for regenerative therapies.
Regemat 3D is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Regemat 3D — Funding & Investors." VCBacked, March 11, 2022, https://www.vcbacked.co/company/regemat-3d. Accessed August 14, 2026.
VCBacked. (2022). Regemat 3D — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/regemat-3d
{{cite web |title=Regemat 3D — Funding & Investors |url=https://www.vcbacked.co/company/regemat-3d |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated